抗腫瘤藥 的英文怎麼說

中文拼音 [kàngzhǒngliúyào]
抗腫瘤藥 英文
antineoplastic; antineoplastic drug
  • 抗 : Ⅰ動詞1 （抵抗; 抵擋） resist; combat; fight 2 （拒絕; 抗拒） refuse; defy 3 （對等） contend with...
  • 腫 : Ⅰ名詞（隆起處） swelling Ⅱ動詞（突起） swell; be swollen
  • 瘤 : 名詞（瘤子） tumour
  • 藥 : Ⅰ名詞1 （藥物） medicine; drug; remedy 2 （某些有化學作用的物質） certain chemicals Ⅱ動詞1 [書面...
  • 腫瘤 : tumour; core （綿羊體內的）; neoplasm; phyma
  1. Synthesis of - d - glucoside - containing 5 - fluorouracil derivatives

    氟尿嘧啶類抗腫瘤藥物的合成
  2. Advance in antitumor agents targeting glutathione s transferase

    轉移酶為靶點的抗腫瘤藥物研究進展
  3. In contrast, most mature somatic cells in human tissues express undetectable or low telomerase activity, implying the existence of a stringent and negative regulatory mechanism. in this study, we report the effects of cisplatin on telomerase activity in human ovarian cancer cells. the special relationship between activity and cancer has a important application value

    順鉑（ ddp ）是卵巢癌化療中最有效的基礎藥物之一，它是一種類烷化劑的抗腫瘤藥物，為細胞周期非特異性藥物，可作用細胞周期的任一時相，利於臨床的聯合用藥，但由於ddp的諸多毒副作用及卵巢癌細胞易產生對其耐藥性，常使化療效果不滿意。
  4. Research result showed that the anticancer mechanisms of allicin were oxidation resistance, inhibiting the form of carcinogens, inducing tumor cello apoptosis, improving cellular immune function and enhancing radiosensitizing effect of antitumor drug

    目前的研究結果顯示，大蒜素的抑癌機制為：抗氧化，抑制致癌物的形成，影響腫瘤細胞的細胞周期並誘導腫瘤細胞調亡，增強機體免疫功能，對抗腫瘤藥物有增敏作用等。
  5. Vitamin c can remission the symptom of cancer patien and lengthen life span, but the relationship of it and telomerase was not reported. cisplatin is widely administrated in cancer therapy, it is cell cycle non - specific agent and is combined with other drugs. the caov3 cells were cultured in medium containing different concentrations vitamin c and for different time

    研究發現，人體內必須的營養物質維生素c （ vc ）可降低抗腫瘤藥的毒副作用，並具有抗腫瘤的能力，給各類晚期癌癥患者大劑量注射vc ，具有顯著緩解腫瘤患者癥狀並延長壽命的作用，但目前對vc抗腫瘤作用機制還不清楚。
  6. Progress in non - classical antitumor platinum drugs

    非經典鉑類抗腫瘤藥物研究
  7. Advances in studies on antitumor drugs originated from plant

    植物來源抗腫瘤藥物研究進展
  8. Kunming guiyan pharmaceutical co., ltd. ( kgp ) is founded by kunming institute of precious metals ( ipm ) together with some other pharmaceutical enterprise, and applys itself to researching and producing platinum - based anticancer drugs

    昆明貴研藥業有限公司是由昆明貴金屬研究所等單位共同出資組建，以生產和開發鉑類金屬抗腫瘤藥物為主的新型制藥企業。
  9. The virginia clinton kelley fund will be part of the national breast cancer coalition fund. clinton and leaders of the advocacy group were announcing it thursday in new york city

    這家以柯林頓母親維吉尼亞柯林頓和抗腫瘤藥物科學家凱萊的名字命名的基金會將隸屬美國乳腺癌聯合基金會。
  10. This review mainly outlines the progress of the non - platinum metallic antitumor drugs in clinical trials

    本文主要就一些已經進入臨床試驗階段的非鉑類抗腫瘤藥物的研究進展作一簡述。
  11. It is a hotspot for tumor treatment research to look for safe and effective antitumor drugs from traditional chinese herbal medicine

    摘要從傳統的中草藥這些天然物質中尋找安全有效的抗腫瘤藥物是目前腫瘤治療研究的一個熱點。
  12. Since the production and purification of lt a 27 are simple, lt a 27 is prospected to be developed to a kind of high efficiency, low toxicity antitumor drug

    採用上述方法大量制備和純化lt 27的過程簡單，適合大規模生產，因此lt 27有望被開發成為一種高效低毒的抗腫瘤藥物。
  13. This work provides a foundation for further research on separation of combinding oligochitosan component of macrophage and elucidation on the immunoregulation mechanism of oligochitosan with macrophage. from this work we endeavor to find the theoretical ground for development of antitumor drugs and functional food from oligochitosan

    通過本實驗為進一步闡明殼寡糖對巨噬細胞的免疫調節機理和分離巨噬細胞殼寡糖結合組分提供一定的實驗依據，為殼寡糖抗腫瘤藥物和功能食品的開發提供理論依據。
  14. The originalities of this paper are : 1, development of a a flow cytometry - based assay for quantitative analysis of cellular proliferation and cytotoxicity in vitro ; 2, the soluble secretion of k. 562 cell lines reduce the number of pbmc, but promote the activity of pbmc in dose - dependent manner ; 3, soluble secretion of k562 cell lines can induce the no production by pbmc, but no only plays a part of the role of soluble secretion of k562 cell lines ; 4, establishing a in vitro model and giving some parameters for sreening and appraising anti - tumor medicine

    本研究的創新點在於： l 、建立了用流式細胞術定量測定細胞增殖和細胞毒性的直接檢測技術； 2發現k562可溶性分泌物劑量依賴性地使pbmc細胞數量減少但活性增加； 3 、 k562可溶性分泌物能誘導pbmc產生no ，但是no的作用並不等同於腫瘤上清的全部作用。 4 、為抗腫瘤藥物篩選提供了一個體外模型，並明確了一些篩選指標。
  15. Effect of hyperglycemia on peroxisome proliferators activated receptors in human glomerular mesangium cells

    六種抗腫瘤藥物影響小鼠精子生成過程的定量組織學比較
  16. Difference in the recovery of hematopoietic function in mice injured by antineoplastic drugs in rotating constant magnetic field with different frequencies

    不同頻率旋轉強恆磁場對抗腫瘤藥物損傷小鼠造血功能恢復效果的差異
  17. Patient reporting of antineoplastic therapy - associated adverse events should be used to complement physician reporting

    抗腫瘤藥的治療相關性不良事件的病人報告應當用作醫生報告的補充。
  18. Many drugs, such as cardiovascular drugs, respiratory drugs, antineoplastic drugs, central nervous system drugs, etc., may induce the occurrence of af

    許多藥物，如心血管系統藥物、呼吸系統藥物、抗腫瘤藥物、中樞神經系統藥物等可誘發心房顫動的發生。
  19. Expression of ephb4 and hif - 1 in lung cancer and its clinical significance

    3提高部分抗腫瘤藥物療效的基礎及臨床研究
  20. It ' s belieed that identifying the cancer stem cells will allow more effectie drugs to be deeloped

    科學家相信鑒定癌幹細胞能幫助抗腫瘤藥物更有效的發展。
分享友人
分享到 Line

分享到臉書